C components that act downstream to C5 and are involved in C5b-9 assembly are not likely to be key factors in CLL, because activation via the AP, which involves the same C5-C9 components, was normal in all subjects' groups. This evidence concerns the gene C9 and B-cell chronic lymphocytic leukemia.